Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Nature
|
September 1, 2022
Screening for generality in asymmetric catalysis
Corin C Wagen, Spencer E McMinn, Eugene E Kwan, et al.
Nature
|
July 2, 2026
Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization
Casey B Roos, S Luke Schulert, Lara E Zetzsche, et al.
Nature
|
November 12, 2025
Synthesis of enantioenriched atropisomers by biocatalytic deracemization
Casey B Roos, S Luke Schulert, Lara E Zetzsche, et al.
Biochemistry
|
October 21, 2024
High-Throughput Algorithmic Optimization of <i>In Vitro</i> Transcription for SARS-CoV-2 mRNA Vaccine Production
Spencer E McMinn, Danielle V Miller, Daniel Yur, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors
Derun Li, Hongjun Zhang, Thomas W Lyons, et al.
Journal of Medicinal Chemistry
|
February 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies
Brandon A Vara, Jongwon Lim, Casey J Moure, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
April 27, 2026
Correction to "Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease"
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Nature
|
September 1, 2022
Screening for generality in asymmetric catalysis
Corin C Wagen, Spencer E McMinn, Eugene E Kwan, et al.
Nature
|
July 2, 2026
Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization
Casey B Roos, S Luke Schulert, Lara E Zetzsche, et al.
Nature
|
November 12, 2025
Synthesis of enantioenriched atropisomers by biocatalytic deracemization
Casey B Roos, S Luke Schulert, Lara E Zetzsche, et al.
Biochemistry
|
October 21, 2024
High-Throughput Algorithmic Optimization of <i>In Vitro</i> Transcription for SARS-CoV-2 mRNA Vaccine Production
Spencer E McMinn, Danielle V Miller, Daniel Yur, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors
Derun Li, Hongjun Zhang, Thomas W Lyons, et al.
Journal of Medicinal Chemistry
|
February 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies
Brandon A Vara, Jongwon Lim, Casey J Moure, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
April 27, 2026
Correction to "Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease"
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Page
of 2